These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38155443)

  • 21. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling.
    Samaratunga H; Montironi R; True L; Epstein JI; Griffiths DF; Humphrey PA; van der Kwast T; Wheeler TM; Srigley JR; Delahunt B; Egevad L;
    Mod Pathol; 2011 Jan; 24(1):6-15. PubMed ID: 20834234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grossing and reporting of testicular tumor specimens : An evidence-based approach.
    Ambekar A; Rao V; Pai SA; Bindhu MR; Midha D; Kaushal S; Patil S; Jagdale R; Soni S; Kulkarni B; Sundaram S; Kumar RM; Desai S; Menon S
    Indian J Cancer; 2020; 57(1):7-12. PubMed ID: 32129294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy.
    Mazzucchelli R; Barbisan F; Tagliabracci A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
    Virchows Arch; 2007 Apr; 450(4):371-8. PubMed ID: 17285325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key issues in handling and reporting radical prostatectomy specimens.
    Srigley JR
    Arch Pathol Lab Med; 2006 Mar; 130(3):303-17. PubMed ID: 16519557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection.
    Kachanov M; Budäus L; Beyersdorff D; Karakiewicz PI; Tian Z; Falkenbach F; Tilki D; Maurer T; Sauter G; Graefen M; Leyh-Bannurah SR
    Eur Urol Focus; 2023 Mar; 9(2):303-308. PubMed ID: 36184537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting tumour location in radical prostatectomy specimens: same-patient comparisons of 21-sample versus sextant biopsy.
    De Laet K; de la Taille A; Ploussard G; Hoznek A; Vordos D; Yiou R; Allory Y; Azoulay S; Abbou C; Salomon L
    BJU Int; 2009 Sep; 104(5):616-20. PubMed ID: 19466953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.
    Kvåle R; Møller B; Wahlqvist R; Fosså SD; Berner A; Busch C; Kyrdalen AE; Svindland A; Viset T; Halvorsen OJ
    BJU Int; 2009 Jun; 103(12):1647-54. PubMed ID: 19154461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer grade downgrading at time of prostatectomy provides risk-stratification insight into future tumor behavior after prostatectomy.
    Wang S; Ryan Russell J; Drescher M; Park A; Legesse T; Kundra V; Tran PT; Phelan M; Naslund M; Minhaj Siddiqui M
    Prostate; 2022 Dec; 82(16):1520-1528. PubMed ID: 35923127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy.
    Drouin SJ; Comperat E; Varinot J; Vaessen C; Bitker MO; Chartier-Kastler E; Mozer P; Shariat SF; Cussenot O; Rouprêt M
    World J Urol; 2014 Apr; 32(2):489-93. PubMed ID: 23723015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focused Submission of Tissue for Radical Prostatectomy Following Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-Targeted Biopsy.
    Fasciano D; Eich ML; Del Carmen Rodriguez Pena M; Rais-Bahrami S; Gordetsky J
    Int J Surg Pathol; 2020 Feb; 28(1):44-50. PubMed ID: 31342804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial.
    Bullock MJ; Srigley JR; Klotz LH; Goldenberg SL
    Am J Surg Pathol; 2002 Nov; 26(11):1400-13. PubMed ID: 12409716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign Prostatic Hyperplasia-Related False-Positive of Prostate-Specific Membrane Antigen-Positron Emission Tomography in the Diagnosis of Prostate Cancer: The Achilles' Heel of Biopsy-Free Radical Prostatectomy?
    Tang W; Tang Y; Qi L; Zhang Y; Tang G; Gao X; Hu S; Cai Y
    J Urol; 2023 Dec; 210(6):845-855. PubMed ID: 37647549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suboptimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy.
    Karsiyakali N; Ozgen MB; Ozveren B; Akbal C; Dincer A; Durak H; Turkeri L
    Urology; 2021 Feb; 148():217-223. PubMed ID: 32871139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is active surveillance a safe alternative in the management of localized prostate cancer? Pathological features of radical prostatectomy specimens in potential candidates for active surveillance.
    Norman Z; Militza P; Andres F; Daniela F; Alejandro M; Catherine S; Juan F
    Int Braz J Urol; 2014; 40(2):154-9. PubMed ID: 24856482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.
    Fanning DM; Kay E; Fan Y; Fitzpatrick JM; Watson RW
    BJU Int; 2010 Mar; 105(5):631-5. PubMed ID: 19732053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Handling and reporting of radical prostatectomy specimens in Europe: a web-based survey by the European Network of Uropathology (ENUP).
    Egevad L; Algaba F; Berney DM; Boccon-Gibod L; Griffiths DF; Lopez-Beltran A; Mikuz G; Varma M; Montironi R;
    Histopathology; 2008 Sep; 53(3):333-9. PubMed ID: 18643930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
    Payrard-Starck C; Fourcade A; An Nguyen T; Tissot V; Doucet L; Marolleau J; Lucas C; Fournier G; Valeri A
    Prog Urol; 2023 Apr; 33(5):265-271. PubMed ID: 36740508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Gleason scores from sextant prostate biopsies and radical prostatectomy specimens.
    Altay B; Kefi A; Nazli O; Killi R; Semerci B; Akar I
    Urol Int; 2001; 67(1):14-8. PubMed ID: 11464109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downgrading of biopsy based Gleason score in prostatectomy specimens.
    Treurniet KM; Trudel D; Sykes J; Evans AJ; Finelli A; Van der Kwast TH
    J Clin Pathol; 2014 Apr; 67(4):313-8. PubMed ID: 24403214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.
    Grignon DJ
    Mod Pathol; 2018 Jan; 31(S1):S96-109. PubMed ID: 29297497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.